Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2026
Download Free Sample Buy Now
Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2026

Global Outlook – By Type (Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits), By Application (Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications), By End User (Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview

• Next-Generation Sequencing (NGS)-Based Molecular Diagnostics market size has reached to $2.26 billion in 2025

• Expected to grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%

• Growth Driver: Increasing Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Travel And Pathogen Spread

• Market Trend: FDA-Approved NGS Panels Enable Comprehensive Detection Of Mutations And Genomic Variations

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that utilizes high-throughput sequencing to analyze genetic material with high accuracy and speed. It enables the detection of genetic variations, mutations, and disease markers at a molecular level, providing deeper insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The main types of next-generation sequencing (NGS)-based molecular diagnostics are instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. Next-generation sequencing instruments are the hardware platforms, including sequencers and automation workstations, used to physically perform high-throughput DNA/RNA sequencing. The various applications include microbiology, infectious diseases, oncology, genetic tests, and others, and cater to several end-users, including research centres and academics, hospitals and clinical laboratories, and others.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics market report bar graph

What Is The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Size and Share 2026?

The next-generation sequencing (ngs)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in genetic disorder testing, development of high-throughput sequencing, rising awareness of molecular diagnostics, adoption in clinical labs, technological improvements in sequencing reagents.

What Is The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Growth Forecast?

The next-generation sequencing (ngs)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to integration of ai and machine learning in diagnostics, expansion of cloud-based genomic platforms, development of portable and point-of-care sequencing devices, rise in personalized medicine applications, collaborations between diagnostics and biotech firms. Major trends in the forecast period include AI-assisted molecular diagnostics, cloud genomic analysis platforms, portable sequencing devices, integration of bioinformatics pipelines, rapid disease marker detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Segmentation

1) By Type: Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits

2) By Application: Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications

3) By End User: Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users

Subsegments:

1) By Instruments: Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware

2) By Reagents And Consumables: Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents

3) By Software And Services: Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services

4) By Panels And Assays: Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays

5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits

What Is The Driver Of The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?

The increasing incidence of infectious diseases is expected to propel the growth of the next-generation sequencing (NGS)-based molecular diagnostics market going forward. Infectious diseases are disorders caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade the body, multiply, and disrupt normal body functions. The prevalence of infectious diseases is increasing as rising travel and migration accelerate the transmission of pathogens across regions and borders. Next-generation sequencing (NGS)-based molecular diagnostics helps detect infectious diseases by providing comprehensive and precise analysis of pathogens. It reduces diagnostic time by simultaneously identifying multiple microorganisms, improving treatment accuracy and patient care. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing incidence of infectious diseases is driving the growth of the next-generation sequencing (NGS)-based molecular diagnostics industry.

Key Players In The Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

Major companies operating in the next-generation sequencing (ngs)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB

Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Trends and Insights

Major companies operating in the next-generation sequencing (NGS)-based molecular diagnostics market are focusing on developing advanced next-generation sequencing (NGS)-based panels to enhance the accuracy, accessibility, and efficiency of genetic testing. NGS panels are targeted sets of genes or genomic regions analyzed simultaneously using NGS technology to detect clinically relevant mutations for faster and more precise molecular diagnostics. For instance, in April 2024, Pillar Biosciences, a US-based diagnostics company, received FDA approval for its oncoReveal CDx pan-cancer solid tumor IVD kit, which analyzes 22 clinically relevant genes in a single multiplex reaction. Designed for use with Illumina’s MiSeq Dx system, the panel supports a sample-to-report time of approximately 48 hours and can process up to 46 clinical samples per run. OncoReveal CDx includes companion diagnostic claims for KRAS (for EGFR-targeted therapy in colorectal cancer) and EGFR (TKI therapy in non–small-cell lung cancer), enabling more comprehensive and efficient detection of actionable genomic alterations to improve clinical decision-making.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?

In January 2023, QIAGEN NV, a Germany-based molecular diagnostics and life sciences company, acquired Verogen Inc. for an undisclosed amount. With this acquisition, QIAGEN aims to strengthen its leadership in human identification and forensic genomics by integrating Verogen’s specialized NGS technologies into its broader molecular diagnostics portfolio, expanding its reach in both public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company that specializes in next-generation sequencing (NGS) solutions for forensic genomics.

Regional Outlook

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market?

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report 2026?

The next-generation sequencing (ngs)-based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (ngs)-based molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.43 billion
Revenue Forecast In 2035 $3.23 billion
Growth Rate CAGR of 7.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Ai-Assisted Molecular Diagnostics

4.2.2 Cloud Genomic Analysis Platforms

4.2.3 Portable Sequencing Devices

4.2.4 Integration Of Bioinformatics Pipelines

4.2.5 Rapid Disease Marker Detection

5. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Research Centers And Academic Institutes

5.2 Hospitals And Clinical Laboratories

5.3 Biopharmaceutical Companies

5.4 Genetic Testing Laboratories

5.5 Contract Research Organizations (Cros)

6. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Segmentation

9.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits

9.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications

9.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users

9.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware

9.5. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents

9.6. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services

9.7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays

9.8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits

10. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

11.1. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

12.1. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

13.1. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

14.1. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

15.1. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

16.1. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

17.1. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

18.1. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

19.1. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

20.1. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

21.1. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

22.1. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

23.1. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

24.1. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

25.1. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

26.1. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

27.1. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

28.1. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

29.1. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

30.1. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

31.1. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

32.1. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

33.1. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

34.1. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regulatory and Investment Landscape

36. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Company Profiles

36.3.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Other Major And Innovative Companies

Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

38. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

40. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Resource Providers
  • Table 6: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Trends
  • Table 10: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major End Users
  • Table 11: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix
  • Table 99: Thermo Fisher Scientific Financial Performance
  • Table 100: Siemens Healthineers AG Financial Performance
  • Table 101: Agilent Technologies Inc. Financial Performance
  • Table 102: Illumina Inc. Financial Performance
  • Table 103: PerkinElmer Inc. Financial Performance
  • Table 104: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Competitive Dashboard
  • Table 106: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 109: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Resource Providers
  • Figure 6: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major Trends
  • Figure 10: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Major End Users
  • Figure 11: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix
  • Figure 99: Thermo Fisher Scientific Financial Performance
  • Figure 100: Siemens Healthineers AG Financial Performance
  • Figure 101: Agilent Technologies Inc. Financial Performance
  • Figure 102: Illumina Inc. Financial Performance
  • Figure 103: PerkinElmer Inc. Financial Performance
  • Figure 104: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Competitive Dashboard
  • Figure 106: Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 109: Global, Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Read More About Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Read More About Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Read More About Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Read More About Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Point-Of-Care Molecular Diagnostics Market Report 2026 - Global Outlook – By Product (Assays And Kits, Instruments And Analyzers), By Application (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted...

Clinical Oncology Next Generation Sequencing Market Report 2026 - Global Outlook – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible...

Molecular Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain react...

Protein Sequencing Market Report 2026 - Global Outlook – By Product And Service (Protein Sequencing Products, Protein Sequencing Services), By Application (Bio-Therapeutics, Genetic Engineering, Other Applications), By E...

RNA Sequencing Services Market Report 2026 - Global Outlook – By Type (Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)), By Sequencing Method (Next Generation Sequencing Methods, Other Sequencing ...

Clinical Next-Generation Sequencing (NGS) Data Analysis Market Report 2026 - Global Outlook – By Solution And Services (NGS Data Analysis Tools, NGS Data Analysis And Sequencing Services, NGS Storage, Management And Clou...

NGS-Based RNA-Sequencing Market Report 2026 - Global Outlook – By Product And Service (Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management), By T...

Next Generation Sequencing Market - By Product Type (Kits And Consumables, Software, Instruments), By Technology (Ion Semiconductor Sequencing, Sequencing by Synthesis, Single-molecule Real-time Sequencing, Other Sequenc...

Frequently Asked Questions

The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics market was valued at $2.26 billion in 2025, increased to $2.43 billion in 2026, and is projected to reach $3.23 billion by 2030.

The global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics market is expected to grow at a CAGR of 7.3% from 2026 to 2035 to reach $3.23 billion by 2035.

Some Key Players in the Next-Generation Sequencing (NGS)-Based Molecular Diagnostics market Include, Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB .

Major trend in this market includes: FDA-Approved NGS Panels Enable Comprehensive Detection Of Mutations And Genomic Variations. For further insights on this market. request a sample here

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us